MannKind Corporation Competitors and Similar CompaniesClear all
MannKind Corporation's competitors and similar companies include Amgen, Assertio, Lexicon Pharmaceuticals and Lilly.
 MannKind Corporation MannKind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for patients. |  Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics. |  Assertio Assertio (formerly Depomed) is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions. |  Lexicon Pharmaceuticals Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology. |  Lilly Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products. | |
Founding Date | Founding Date 1991 | Founding Date 1980 | Founding Date 1995 | Founding Date 1995 | Founding Date 1876 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Westlake Village, US HQ Danbury, US | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Diegem, BE Santo Amaro, BR see more | Locations Lake Forest, US HQ | Locations The Woodlands, US HQ Jersey, JE Atlanta, US Bernards, US Birmingham, US Boston, US Charlotte, US see more | Locations Indianapolis, US HQ Buenos Aires, AR Sydney, AU Wien, AT Brussel, BE São Paulo, BR Toronto, CA see more |
Employees | Employees 39513% increase | Employees 25,200 | Employees 3058% increase | Employees 20216% increase | Employees 47,0009% increase |
Valuation ($) | Valuation ($) 1.9 b | Valuation ($) 170.4 b | Valuation ($) 104.9 m | Valuation ($) 737.4 m | Valuation ($) 903.4 b |
Financial | |||||
Revenue (est.) | Revenue (est.) $349m (FY, 2025) | Revenue (est.) $36.8b (FY, 2025) | Revenue (est.) $118.7m (FY, 2025) | Revenue (est.) $49.8m (FY, 2025) | Revenue (est.) $65.2b (FY, 2025) |
Cost of goods | Cost of goods $26.8m (FY, 2025) | Cost of goods $12b (FY, 2025) | Cost of goods N/A | Cost of goods $274k (FY, 2025) | Cost of goods $11.1b (FY, 2025) |
Gross profit | Gross profit $322.2m (FY, 2025) | Gross profit $24.7b (FY, 2025) | Gross profit N/A | Gross profit $49.5m (FY, 2025) | Gross profit $54.1b (FY, 2025) |
Net income | Net income $5.9m (FY, 2025) | Net income $7.7b (FY, 2025) | Net income ($30.4m) (FY, 2025) | Net income ($50.3m) (FY, 2025) | Net income $20.6b (FY, 2025) |
Operating ⚠ | |||||
Countries | Countries N/A | Countries 100 (FY, 2020) | Countries N/A | Countries N/A | Countries 120 (FY, 2021) |
Patents (US) | Patents (US) N/A | Patents (US) 31 (FY, 2020) | Patents (US) 12 (FY, 2020) | Patents (US) N/A | Patents (US) N/A |
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products 20 (FY, 2020) | Phase I Trials Products N/A | Phase I Trials Products 1 (FY, 2016) | Phase I Trials Products 27 (FY, 2019) |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products 5 (FY, 2020) | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products 8 (FY, 2021) |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products 11 (FY, 2020) | Phase III Trials Products N/A | Phase III Trials Products 2 (FY, 2016) | Phase III Trials Products 10 (FY, 2021) |
Products | Products N/A | Products N/A | Products 8 (FY, 2020) | Products 1 (FY, 2016) | Products N/A |
Funding | |||||
Total funding raised | Total funding raised $ 200m | Total funding raised N/A | Total funding raised $ 42.5m | Total funding raised $ 244.7m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Amgen
HQ
Thousand Oaks, US
Employees
25,200
Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
View companyAssertio
HQ
Lake Forest, US
Employees
30
Assertio (formerly Depomed) is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions.
View companyLexicon Pharmaceuticals
HQ
The Woodlands, US
Employees
202↑ 16% increase
Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
View companyLilly
HQ
Indianapolis, US
Employees
47,000↑ 9% increase
Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products.
View company